India’s Kidney Trade Why It Keeps Hiding in Plain Sight

A kidney sale in India is not hidden because nobody can see it. It is hidden because each actor can explain away their part: the donor is “related”, the papers are “verified”, the hospital has “approval”, and the patient is desperate.
On paper, the law is clear. Commercial dealing in human organs is banned under the Transplantation of Human Organs Act, now commonly referred to with later amendments as the Transplantation of Human Organs and Tissues framework. A transplant between unrelated people needs scrutiny from an authorisation committee. A hospital must follow transplant rules. A broker has no lawful place in the process.
In practice, the kidney trade India keeps producing follows a repeating chain. A debt-ridden worker is approached. A broker offers a life-changing amount. Documents are arranged to show a false family relationship or a supposedly altruistic donation. A hospital receives the file. A patient with money gets a transplant. The person who gave the kidney often receives much less than promised, then disappears from the medical system.
The result is a market that is illegal, visible and resilient.
This post is informational only. It is not legal or medical advice.

The law bans organ sales but demand keeps creating a market
India’s transplant law tries to separate donation from trade. It permits organ donation from close relatives, and it allows some unrelated donations only after approval. The basic logic is sound: a person may donate out of family duty or genuine altruism, but nobody should be pushed by poverty into selling a body part.
That line is hard to defend when demand is so much larger than supply.
NOTTO estimates that about 2.5 lakh Indians need a kidney every year. Against that need, only around 14,500 kidney transplants were recorded in 2025, and most used living donors. The gap is not a rounding error. It is the main economic force behind organ trafficking India continues to confront.
Kidney failure has a brutal arithmetic. Dialysis can keep a patient alive, but it is expensive, tiring and often difficult to access consistently. A transplant can offer a better quality of life for many patients, but a legal kidney is hard to find. Cadaver donation remains limited. Family donors are not always medically suitable. Waiting is frightening.
That fear creates a market signal. A patient, or the patient’s family, may not begin by seeking an illegal organ. They begin by seeking survival. Brokers convert that desperation into a transaction.
At the other end of the chain is poverty. A worker with debt, medical bills, family pressure or unstable employment may see a kidney sale as a one-time exit. Brokers know this. They do not usually approach people with long-term security. They look for people who are already cornered.
The current system leaves two groups exposed:
Patients with kidney failure
Poor potential donors
Long waits, limited cadaver donation, pressure to find a transplant quickly
Debt, informal work, weak legal protection, fear of police and hospitals
The law tries to criminalise the market, but the market is fed by scarcity. When a legal route works for too few people, an illegal route does not vanish. It becomes more organised.
The supply chain is simple because each step looks official
The illegal kidney market does not need a dramatic hiding place. It often works through ordinary-looking paperwork.
A typical pattern has four parts.
Stage | How it can appear lawful | What may be happening underneath |
Recruitment | A donor comes forward voluntarily | A broker has targeted a poor person and promised money |
Documentation | The donor is shown as related or altruistic | Papers may be forged or stories coached |
Approval | A committee clears the transplant | Verification may be weak or compromised |
Surgery | A licensed hospital performs the transplant | The commercial deal is kept outside the file |
This is why enforcement is difficult. The illegal payment may not appear in hospital records. The broker may not have a formal role. The donor may be trained to repeat a story. The patient may claim they believed the donation was lawful.
The authorisation committee is supposed to be a barrier against abuse. In cases involving unrelated donors, it should test the relationship, the motive, the absence of payment and the donor’s understanding of the risks. That is not a minor paperwork function. It is the checkpoint between lawful donation and commercial extraction.
When a committee becomes a rubber stamp, the whole system is weakened.
The problem is not only corruption. It can also be poor design. Committees may lack time, independent investigators, shared databases, language support, psychological assessment capacity and post-approval audit systems. If a donor has been coached, threatened or paid in cash, a short interview inside a formal setting may not reveal the truth.
This creates a structural weakness. India tends to react strongly after a racket is exposed, but the risks build long before a police case arrives.

Kanpur and Namakkal show the same pattern years apart
The pattern has appeared across states and across years. Two cases, separated by time and geography, show why one-time crackdowns are not enough.
In 2019, Kanpur police uncovered a network reportedly linked to hospitals in Delhi. Reports at the time said donors were paid around ₹2 lakh to ₹3 lakh, while recipients paid up to ₹80 lakh. Even allowing for variations in reporting and case details, the spread between the donor’s payment and the recipient’s cost shows the basic economics of the trade.
The donor bears the health risk. The broker captures the margin. The patient pays the crisis price.
In 2025, a racket surfaced in Namakkal, Tamil Nadu. Brokers allegedly approached power-loom workers, many of them women, and promised ₹5 lakh to ₹10 lakh. The Madras High Court said the racket was thriving. Two hospitals had transplant licences suspended. The state later filed charge sheets against twelve accused.
The Namakkal kidney racket matters for more than the number of accused. It exposed how vulnerable workers can become a donor pool. Power-loom work is physically demanding and often tied to insecure income. Debt and wage pressure can make a large promised sum feel rational, even when the health and legal risks are severe.
The response also showed the limits of scandal-led governance. Hospitals faced action. Brokers and accused persons faced proceedings. Tamil Nadu’s health minister moved against the Namakkal district authorisation committee after the case surfaced. That step matters, but timing matters too. If the committee is the checkpoint, reform cannot wait until after the gate has failed.
There is a deeper question here: how many illegal transplants were stopped by committees before they happened, and how many were approved because the documents looked tidy?
The public usually sees organ trafficking only after police action. By then, the surgery may already be done, the money moved, and the donor left without meaningful care. The scandal becomes visible after the harm becomes difficult to reverse.
The poorest donor pays twice
The language of “seller” can be misleading. It suggests a person who enters a market and receives a fair price. In many kidney trafficking cases, the person at the bottom is not a seller in any meaningful sense. They are recruited under pressure, given partial information, promised more than they receive, and left to manage the consequences alone.
The first loss is physical. Kidney donation can be safe when it is legal, medically screened, voluntary and followed by proper care. That is the model transplant medicine depends on. An illegal sale is different. The donor may hide medical history, skip counselling, misunderstand long-term risks, or avoid follow-up because they fear exposure.
The second loss is financial. The promised amount may be reduced after surgery. The broker may take a large cut. Debt may absorb the money within weeks. If health problems affect work capacity, the donor can end up worse off than before.
The third loss is legal and social. A donor who complains may fear being treated as an accused person. They may worry about police, hospital authorities, employers or family members. They may also carry stigma, especially if the sale exposes debt or domestic pressure.
That fear protects the network.
A legal system that treats the donor mainly as a participant in crime, rather than as a potential victim of trafficking and exploitation, will receive fewer complaints. Brokers understand this. So do hospitals that look away. Silence becomes part of the business model.
There is also a gendered dimension in some labour settings. The Namakkal reports described brokers approaching many women power-loom workers. That does not mean women are the only targets. It does show how debt, family obligation and informal work can fall heavily on women, particularly where wages are low and bargaining power is weak.
The harm does not end at discharge. A person who has sold a kidney may need long-term monitoring for blood pressure, kidney function and general health. If the transplant was illegal, that follow-up may not happen. The system that was precise enough to remove an organ becomes vague when the donor needs care.
A transplant racket is not only a crime scene. It is also a failed welfare system, a failed audit system and a failed medical follow-up system.
Hospitals are not passive venues in this system
Illegal kidney transplants cannot happen at scale without medical infrastructure. A broker can recruit. A document agent can forge. A recipient can pay. Yet the surgery needs a hospital, surgeons, testing, anaesthesia, operating theatres and records.
That does not mean every hospital involved in a case is guilty. It does mean licensed transplant centres carry a high duty of suspicion.
Hospitals know the red flags. They include:
A donor and recipient who cannot clearly explain their relationship
A sudden appearance of distant relatives from poor backgrounds
Inconsistent identity documents
A donor who seems coached or fearful
Gaps between stated income and the cost of travel, stay or surgery
Little clarity on who arranged the contact
A donor unwilling or unable to describe long-term medical risks
A hospital that treats approval as somebody else’s problem weakens the law. The authorisation committee may clear the file, but the hospital still controls the transplant pathway. Internal ethics committees, transplant coordinators and treating teams should document doubts and pause when a story does not hold.
There is also a data problem. If each hospital and district committee works in isolation, networks can shift from one place to another. A broker exposed in one district may reappear under another arrangement. A donor pool may move across state lines. A recipient may search multiple hospitals until one accepts the paperwork.
India needs stronger data links without turning donors into surveillance targets. The aim should be to identify suspicious patterns, not punish poor people seeking help. For example, audit systems can track unusual clusters of unrelated donations, repeated document witnesses, common addresses, repeated facilitators, and high-risk approval patterns.
The point is not to slow every transplant with suspicion. Delay can cost lives. The point is to focus scrutiny where the risk is highest.

The approval process needs routine audits, not only punishment after scandal
The district authorisation committee is central to the legal transplant system. It is also one of the least publicly understood parts of the process.
A strong committee should ask hard questions before surgery:
Is the donor a near relative, and is that relationship documented reliably?
If not related, what is the real reason for donation?
Has the donor been promised money, employment, debt relief or other benefit?
Has the donor received independent counselling?
Does the donor understand short-term and long-term risks?
Can the donor refuse without pressure?
Is there any broker, agent or middle person involved?
Does the financial profile of the parties raise concerns?
The committee should not rely only on a scripted interview. Coached answers are cheap. Verification needs field checks in high-risk cases, independent translators where needed, social work assessment, and time away from the recipient’s family or any facilitator.
After surgery, approvals should be audited. The audit should not wait for police to uncover a racket. It should sample cases, compare documents, interview donors after recovery, and examine hospital-level patterns.
A useful audit system would include four layers.
Audit layer | What it should examine |
Case file review | Relationship documents, consent forms, income details and medical notes |
Donor follow-up | Whether the donor received care, counselling and promised medical review |
Pattern analysis | Clusters by hospital, district, broker-like contacts or repeated witnesses |
Accountability review | Whether committee members missed clear warning signs |
The hardest part is accountability. Government doctors on committees may already carry heavy workloads. Some may lack training in trafficking indicators. Others may face local pressure. A reform plan should separate honest error from wilful blindness or corruption, but it cannot ignore either.
Training alone will not solve the problem. Any system can be trained and still fail if nobody checks outcomes. Committees need clear protocols, digital records, independent audits and consequences when patterns show repeated failure.
The Namakkal case shows why this matters. Action against a committee after a racket surfaces is better than no action. Still, if the approval checkpoint only becomes visible after scandal, the system is operating backwards.
The legal supply of kidneys must widen
Enforcement is necessary, but enforcement alone cannot close the gap between need and supply.
India needs more legal, ethical kidney availability. That means improving deceased organ donation, strengthening transplant coordination and supporting families through the donation process. It also means making the public health system more capable of identifying potential deceased donors and preserving organs lawfully.
Cadaver donation is sensitive. Families face grief, religious questions, mistrust of hospitals and confusion about brain death. A better system cannot be built only through slogans. It needs trained counsellors, transparent hospital processes, quick certification, organ retrieval teams and public trust.
The organ donation shortage India faces is not only a medical problem. It is administrative. It involves ambulance systems, ICU capacity, death certification, transplant registries, grief counselling, and fair allocation.
Living donation also needs reform. India relies heavily on living kidney donors, usually family members. That will continue. So protections must improve for lawful donors too. A person donating to a relative should receive proper counselling, independent consent review and follow-up care. If lawful donors feel abandoned, public trust falls. If public trust falls, illegal brokers gain space.
A healthier transplant system would do three things at once:
Protect the vulnerable donor
Treat trafficked or deceived donors as people needing protection, care and legal support. Fear of prosecution should not block complaints.
Punish the profit chain
Focus criminal enforcement on brokers, document forgers, corrupt officials, complicit medical staff and organised networks.
Increase lawful donation
Build deceased donation capacity and make fair allocation visible, credible and efficient.
India cannot police its way out of a shortage. It must reduce the shortage while policing exploitation.

Reform should start where the trade is most predictable
The kidney trade survives because it is predictable. Brokers look for debt. Patients look for speed. Hospitals look at paperwork. Committees look for formal compliance. Police often enter after the transaction is complete.
A serious response should begin earlier.
The first priority is a donor-protection pathway. A poor person who was recruited, misled or underpaid should be able to seek help without facing immediate criminal exposure. That pathway should include medical follow-up, legal aid, witness protection where needed, and a clear route to compensation from seized proceeds or victim support funds.
The second priority is authorisation committee reform. Committees should use risk scoring for unrelated donations, mandatory independent donor interviews, documented social assessments and random audits. Where a district shows repeated suspicious approvals, the state should intervene before a scandal forces action.
The third priority is hospital accountability. Transplant centres should face regular compliance audits, not only licence suspension after headlines. Suspensions matter, but they are blunt tools. Regulators also need intermediate sanctions, mandatory corrective plans and public reporting of transplant approval data in a privacy-safe form.
The fourth priority is better national and state data. Patterns should be visible across hospitals and districts. If the same addresses, witnesses, facilitators or document types keep appearing, the system should flag them.
The fifth priority is deceased donation capacity. This is slower than enforcement, but it is central. More lawful organs reduce the pressure that brokers exploit.
None of this removes the emotional reality for patients with kidney failure. Families will keep trying to save loved ones. That is why the state must make the lawful path wider and more reliable. A desperate patient should not have to choose between waiting indefinitely and entering a criminal market.
The illegal kidney trade does not thrive because the law is absent. It thrives because the law is narrow at the point of need, weak at the point of approval, and late at the point of enforcement.
India already knows the pattern. Kanpur showed the margins. Namakkal showed the labour pipeline. The approval committees show the institutional gap. NOTTO’s numbers show the shortage.
The next step is not another round of shock after the next racket. It is a system that protects donors before they disappear, audits approvals before they become scandals, and expands lawful donation before scarcity turns into a market.
Until that happens, the trade will keep hiding in plain sight, not in the shadows, but inside documents that look official enough to pass.


